FilingSEC EDGAR6-K
Can-Fite BioPharma Announces Exercise of Warrants for Approximately $4.0 Million in Gross Proceeds
· SEC accepted
StageDefinitive Agreement
Filing content
Can-Fite BioPharma announced the exercise of warrants for approximately $4.0 million in gross proceeds and will issue new warrants in consideration.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…